Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Recruiting × Escitalopram × Clear all

Phase

Status

Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 200 Carboplatin 183 Cisplatin 166 Specimen Handling 165 Magnetic Resonance Spectroscopy 142 Radiotherapy 122 Bevacizumab 118 Gemcitabine 108 Cyclophosphamide 107 Drug Therapy 103 Capecitabine 96 Paclitaxel 94 Nivolumab 93 venetoclax 92 Biopsy 84 Oxaliplatin 81 durvalumab 72 tislelizumab 69 Rituximab 68 atezolizumab 60 Etoposide 59 Docetaxel 59 Radiosurgery 58 Fluorouracil 58 toripalimab 57 Pemetrexed 57 Dexamethasone 54 Azacitidine 53 lenvatinib 52 sintilimab 49

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03728673 2025-06-22

A Study Utilizing Escitalopram in Glioma Patients

University of Nebraska

Phase 2 Recruiting

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡